Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
22.3M
-
Shares change
-
+22.3M
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
+$1.13B
-
Number of buys
-
92
-
Price
-
$50.40
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q3 2019
92 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q3 2019.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
of 114M outstanding shares and own 19.53% of the company stock.
Largest 10 shareholders include Foresite Capital Management II, LLC (6.84M shares), FMR LLC (2.75M shares), VHCP Management II, LLC (1.79M shares), JS Capital Management LLC (1.68M shares), WELLS FARGO & COMPANY/MN (915K shares), BlackRock Inc. (913K shares), LORD, ABBETT & CO. LLC (733K shares), VANGUARD GROUP INC (727K shares), PRICE T ROWE ASSOCIATES INC /MD/ (681K shares), and VICTORY CAPITAL MANAGEMENT INC (562K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.